Home » Arteriocyte Approved to Move Forward With Critical Limb Ischemia Trial
Arteriocyte Approved to Move Forward With Critical Limb Ischemia Trial
Arteriocyte announced approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.
CNBC
CNBC
Upcoming Events
-
07May
-
14May
-
30May